Developer docs
API playgroundTry for free, no card

Search company profiles

Nanolive

Full company profile

uuid0002283

Namestring
Nanolive
Legal namestring
Nanolive SA
Websiteurl
nanolive.ch
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Nanolive SA is a Swiss life-sciences instrumentation company founded in 2013 and headquartered in Ecublens, Switzerland, that develops and sells automated, label-free live-cell imaging and analysis systems for biotech and pharmaceutical research customers. Its core technology is holotomography — a proprietary digital holographic microscopy technique that generates 3D refractive-index maps of living cells without dyes, labels, or phototoxic excitation, enabling long-term, non-invasive observation of cellular processes in near-native conditions.

The product architecture follows a platform-plus-modules model. The 3D Cell Explorer family (3D Cell Explorer, 3D Cell Explorer-fluo, and the automated high-content 3D Cell Explorer 96focus) constitutes the hardware backbone; EVE Explorer and EVE Analytics form the AI-powered software layer; and a suite of application-specific digital assays (LIVE Cytotoxicity Assay, Smart Mitochondrial Assay LIVE, Smart Lipid Droplet Assay LIVE, LIVE T Cell Assay) provides push-button quantitative readouts, including the ability to retroactively re-analyze previously captured image data. Accessories (plates, dishes, lids, multi-use platforms), training programs, and service contracts complete the offering.

Nanolive monetizes through a B2B enterprise motion: high-ASP microscope sales (one-time hardware revenue), recurring software/assay subscriptions, and consumables, all sold through direct field sales and an international distributor network with quote-based, multi-year contracts. End customers include major pharmaceutical and biotechnology firms (Amgen, Idorsia), academic and translational centers (MIT Koch Institute for Integrative Cancer Research, ULL, LUCA), and emerging verticals such as cosmetics safety testing. Total capital raised to date is approximately $22.2 million across Series C rounds in 2022, with strategic backing from Taiwania Capital and a US-based NASDAQ-listed investor.

Short descriptiontext

Nanolive SA is a Swiss life-sciences instrumentation company that builds automated, label-free 3D live-cell imaging microscopes (holotomography) and AI-powered digital assays (EVE platform) for biotech, pharmaceutical, immuno-oncology, cell biology, and cosmetics research customers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEcublens, Switzerland
HQ citystring
Ecublens
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
live cell imaging, label-free microscopy, holotomography technology, digital cell analysis, drug discovery tools
Industry1 code
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Scientific Instrumentation
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Hardware Sales - 3D Cell Explorer Platforms
TypeOne Time License
Description

Sale of high-precision live cell imaging microscopes including 3D Cell Explorer 96focus, 3D Cell Explorer-fluo, and 3D Cell Explorer models. These are research instruments sold to biotech and pharma labs.

nanolive.com
2AI-Powered Software Analytics
TypeSubscription Recurring
Description

EVE Explorer and EVE Analytics software platforms providing AI-driven analysis of imaging data. Sold as integrated solutions with hardware or potentially as separate software licenses.

nanolive.com
3Digital Assays (EVE Assays)
TypeSubscription Recurring
Description

Application-specific digital assays including LIVE Cytotoxicity Assay, Smart Mitochondrial Assay LIVE, Smart Lipid Droplet Assay LIVE, and LIVE T Cell Assay. These are specialized analytical tools for specific research applications.

nanolive.com
4Accessories and Consumables
TypeOne Time License
Description

Sale of accessories including LIVE96 Plates & Lids, 35mm u-Dishes, DIC lids with glass window, and Multi-Use Platform

nanolive.com
Marketing channels13 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Pricing details1 tier
1Enterprise quote-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing available. Research equipment sold directly to biotech and pharma companies with custom quoting based on configuration and volume.

nanolive.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
13D Cell Explorer
Description

Live cell imaging platform using holotomography technology for label-free 3D imaging.

nanolive.com
+8 more records
Core offering1 text field

Nanolive develops and sells label-free, non-invasive 3D live cell imaging microscopes based on its proprietary holotomography technology, paired with AI-powered digital analytics software (EVE Explorer, EVE Analytics) and application-specific digital assays for cytotoxicity, mitochondria, lipid droplets, and T cell analysis. The integrated hardware-software platform targets biotech, pharmaceutical, cosmetics, and academic research customers, enabling long-term monitoring of living cells without dyes, labels, or phototoxicity.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • CAGR of 20.4% in digital holographic microscopy market from 2024-2033
Product overview1 text field

Nanolive offers a platform-plus-modules architecture centered on its holotomography-based 3D Cell Explorer imaging family (3D Cell Explorer, 3D Cell Explorer-fluo, and 3D Cell Explorer 96focus), which provides automated label-free live cell imaging. The portfolio integrates AI-powered digital analytical solutions through the EVE Explorer and EVE Analytics platforms, supplemented by application-specific assay modules including LIVE Cytotoxicity Assay, Smart Lipid Droplet Assay LIVE, Smart Mitochondrial Assay LIVE, and LIVE T Cell Assay. Hardware accessories (LIVE96 Plates & Lids, 35 mm μ-Dishes, DIC lids with glass window, Multi-Use Platform) and support services (Training Programs, Service contracts) complete the ecosystem.

Product and service15 records
13D Cell Explorer 96focus
CategoryLive Cell Imaging Microscope
Description

Automated high-content label-free live cell imaging platform with integrated AI-powered digital assay analysis, designed for unlimited multiplexed live cell analysis with streamlined autonomous workflows. Sold to biotech and pharmaceutical research labs.

23D Cell Explorer-fluo
CategoryLive Cell Imaging Microscope
Description

3D cell microscope combining holotomography with fluorescence imaging capabilities for multi-modal cellular analysis. Targets research labs needing both label-free and fluorescence modalities.

33D Cell Explorer
CategoryLive Cell Imaging Microscope
Description

Core 3D holographic microscope platform based on holotomography technology for label-free live cell imaging. The base Nanolive microscope for research customers.

4EVE Explorer
CategoryCell Analysis Software
Description

AI-powered live cell analysis software for exploring and visualizing cellular data generated by Nanolive imaging platforms. Sold as a subscription/recurring software license to imaging platform users.

5EVE Analytics
CategoryCell Analysis Software
Description

Advanced AI analytics platform for quantitative assessment of live cell imaging data, enabling high-content phenotypic screening and data-driven insights for research customers.

6LIVE Cytotoxicity Assay
CategoryDigital Assay
Description

AI-powered digital assay for label-free profiling of cell health and death, distinguishing between living, apoptotic, and necrotic cells without dyes. Used in drug discovery and toxicology research.

7Smart Lipid Droplet Assay LIVE
CategoryDigital Assay
Description

AI-driven digital assay for measuring lipid droplet characteristics at population, cellular, and individual droplet levels label-free. Targets metabolism and cell biology research.

8Smart Mitochondrial Assay LIVE
CategoryDigital Assay
Description

World's first fully automated solution for non-invasive, quantitative assessment of mitochondrial dynamics using high-resolution label-free imaging and AI-driven analysis for drug discovery applications.

9LIVE T Cell Assay
CategoryDigital Assay
Description

AI-powered digital assay for measuring and characterizing how live T cells find, bind, stress, and serial kill target cells in immuno-oncology research.

10LIVE96 Plates & Lids
CategoryImaging Accessory
Description

Specialized plates and lids designed for use with the 3D Cell Explorer 96focus platform for automated live cell imaging workflows.

1135 mm μ-Dishes
CategoryImaging Accessory
Description

Micro-dishes for live cell imaging sample preparation compatible with Nanolive imaging platforms.

12DIC lids with glass window
CategoryImaging Accessory
Description

Differential interference contrast lids with glass windows for specialized imaging applications with Nanolive microscopes.

13Multi-Use Platform
CategoryImaging Accessory
Description

Versatile platform accessory for accommodating various sample types and imaging configurations with Nanolive microscopes.

14Training Programs
CategoryProfessional Service
Description

Training programs that help users maximize the value of their Nanolive imaging and analysis systems.

15Service Contracts
CategoryProfessional Service
Description

Comprehensive service contracts for ongoing support and maintenance of Nanolive imaging systems.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nanolive

Scientific Instrumentationnanolive.ch

Nanolive SA is a Swiss life-sciences instrumentation company that builds automated, label-free 3D live-cell imaging microscopes (holotomography) and AI-powered digital assays (EVE platform) for biotech, pharmaceutical, immuno-oncology, cell biology, and cosmetics research customers globally.

What Nanolive does

Nanolive SA is a Swiss life-sciences instrumentation company founded in 2013 and headquartered in Ecublens, Switzerland, that develops and sells automated, label-free live-cell imaging and analysis systems for biotech and pharmaceutical research customers. Its core technology is holotomography — a proprietary digital holographic microscopy technique that generates 3D refractive-index maps of living cells without dyes, labels, or phototoxic excitation, enabling long-term, non-invasive observation of cellular processes in near-native conditions.

The product architecture follows a platform-plus-modules model. The 3D Cell Explorer family (3D Cell Explorer, 3D Cell Explorer-fluo, and the automated high-content 3D Cell Explorer 96focus) constitutes the hardware backbone; EVE Explorer and EVE Analytics form the AI-powered software layer; and a suite of application-specific digital assays (LIVE Cytotoxicity Assay, Smart Mitochondrial Assay LIVE, Smart Lipid Droplet Assay LIVE, LIVE T Cell Assay) provides push-button quantitative readouts, including the ability to retroactively re-analyze previously captured image data. Accessories (plates, dishes, lids, multi-use platforms), training programs, and service contracts complete the offering.

Nanolive monetizes through a B2B enterprise motion: high-ASP microscope sales (one-time hardware revenue), recurring software/assay subscriptions, and consumables, all sold through direct field sales and an international distributor network with quote-based, multi-year contracts. End customers include major pharmaceutical and biotechnology firms (Amgen, Idorsia), academic and translational centers (MIT Koch Institute for Integrative Cancer Research, ULL, LUCA), and emerging verticals such as cosmetics safety testing. Total capital raised to date is approximately $22.2 million across Series C rounds in 2022, with strategic backing from Taiwania Capital and a US-based NASDAQ-listed investor.

Nanolive firmographics

Firmographics
Name
Nanolive
Legal name
Nanolive SA
Website
https://nanolive.ch
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
Nanolive SA is a Swiss life-sciences instrumentation company that builds automated, label-free 3D live-cell imaging microscopes (holotomography) and AI-powered digital assays (EVE platform) for biotech, pharmaceutical, immuno-oncology, cell biology, and cosmetics research customers globally.
Ownership category
akta.pro rank

Nanolive industry classification

Industry
Product category
Scientific Instrumentation
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments

Keywords

  • Live cell imaging
  • Label-free microscopy
  • Holotomography technology
  • Digital cell analysis
  • Drug discovery tools

Where Nanolive is headquartered

Location

Headquarters

HQ city
Ecublens
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

Nanolive business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

  1. Hardware Sales - 3D Cell Explorer Platforms: Sale of high-precision live cell imaging microscopes including 3D Cell Explorer 96focus, 3D Cell Explorer-fluo, and 3D Cell Explorer models. These are research instruments sold to biotech and pharma labs.
  2. AI-Powered Software Analytics: EVE Explorer and EVE Analytics software platforms providing AI-driven analysis of imaging data. Sold as integrated solutions with hardware or potentially as separate software licenses.
  3. Digital Assays (EVE Assays): Application-specific digital assays including LIVE Cytotoxicity Assay, Smart Mitochondrial Assay LIVE, Smart Lipid Droplet Assay LIVE, and LIVE T Cell Assay. These are specialized analytical tools for specific research applications.
  4. Accessories and Consumables: Sale of accessories including LIVE96 Plates & Lids, 35mm u-Dishes, DIC lids with glass window, and Multi-Use Platform

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise quote-based pricing

Go-to-market motion1 record

Distribution channels2 records

Marketing channels13 records

Nanolive product offering

Product offering

Core offering

Nanolive develops and sells label-free, non-invasive 3D live cell imaging microscopes based on its proprietary holotomography technology, paired with AI-powered digital analytics software (EVE Explorer, EVE Analytics) and application-specific digital assays for cytotoxicity, mitochondria, lipid droplets, and T cell analysis. The integrated hardware-software platform targets biotech, pharmaceutical, cosmetics, and academic research customers, enabling long-term monitoring of living cells without dyes, labels, or phototoxicity.

Product overview

Nanolive offers a platform-plus-modules architecture centered on its holotomography-based 3D Cell Explorer imaging family (3D Cell Explorer, 3D Cell Explorer-fluo, and 3D Cell Explorer 96focus), which provides automated label-free live cell imaging. The portfolio integrates AI-powered digital analytical solutions through the EVE Explorer and EVE Analytics platforms, supplemented by application-specific assay modules including LIVE Cytotoxicity Assay, Smart Lipid Droplet Assay LIVE, Smart Mitochondrial Assay LIVE, and LIVE T Cell Assay. Hardware accessories (LIVE96 Plates & Lids, 35 mm μ-Dishes, DIC lids with glass window, Multi-Use Platform) and support services (Training Programs, Service contracts) complete the ecosystem.

Differentiator

Problem solved

Functional benefit

Brands

  • 3D Cell Explorer: Live cell imaging platform using holotomography technology for label-free 3D imaging.
  • 3D Cell Explorer 96focus
  • 3D Cell Explorer-fluo
  • EVE Explorer
  • EVE Analytics
  • Smart Mitochondrial Assay LIVE
  • LIVE Cytotoxicity Assay
  • Smart Lipid Droplet Assay LIVE
  • LIVE T Cell Assay

Products and services

  • 3D Cell Explorer 96focus Automated high-content label-free live cell imaging platform with integrated AI-powered digital assay analysis, designed for unlimited multiplexed live cell analysis with streamlined autonomous workflows. Sold to biotech and pharmaceutical research labs.
  • 3D Cell Explorer-fluo 3D cell microscope combining holotomography with fluorescence imaging capabilities for multi-modal cellular analysis. Targets research labs needing both label-free and fluorescence modalities.
  • 3D Cell Explorer Core 3D holographic microscope platform based on holotomography technology for label-free live cell imaging. The base Nanolive microscope for research customers.
  • EVE Explorer AI-powered live cell analysis software for exploring and visualizing cellular data generated by Nanolive imaging platforms. Sold as a subscription/recurring software license to imaging platform users.
  • EVE Analytics Advanced AI analytics platform for quantitative assessment of live cell imaging data, enabling high-content phenotypic screening and data-driven insights for research customers.
  • LIVE Cytotoxicity Assay AI-powered digital assay for label-free profiling of cell health and death, distinguishing between living, apoptotic, and necrotic cells without dyes. Used in drug discovery and toxicology research.
  • Smart Lipid Droplet Assay LIVE AI-driven digital assay for measuring lipid droplet characteristics at population, cellular, and individual droplet levels label-free. Targets metabolism and cell biology research.
  • Smart Mitochondrial Assay LIVE World's first fully automated solution for non-invasive, quantitative assessment of mitochondrial dynamics using high-resolution label-free imaging and AI-driven analysis for drug discovery applications.
  • LIVE T Cell Assay AI-powered digital assay for measuring and characterizing how live T cells find, bind, stress, and serial kill target cells in immuno-oncology research.
  • LIVE96 Plates & Lids Specialized plates and lids designed for use with the 3D Cell Explorer 96focus platform for automated live cell imaging workflows.
  • 35 mm μ-Dishes Micro-dishes for live cell imaging sample preparation compatible with Nanolive imaging platforms.
  • DIC lids with glass window Differential interference contrast lids with glass windows for specialized imaging applications with Nanolive microscopes.
  • Multi-Use Platform Versatile platform accessory for accommodating various sample types and imaging configurations with Nanolive microscopes.
  • Training Programs Training programs that help users maximize the value of their Nanolive imaging and analysis systems.
  • Service Contracts Comprehensive service contracts for ongoing support and maintenance of Nanolive imaging systems.

Quantifiable outcome

  • CAGR of 20.4% in digital holographic microscopy market from 2024-2033

Companies that use Nanolive

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Nanolive technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature4 records

Nanolive partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Nanolive competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

Nanolive social profiles

Digital presence

Nanolive financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nanolive leadership team

Management profile

Number of profiles

Profiles7 records

Nanolive funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nanolive M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nanolive

What does Nanolive do?

Nanolive develops and sells label-free, non-invasive 3D live cell imaging microscopes based on its proprietary holotomography technology, paired with AI-powered digital analytics software (EVE Explorer, EVE Analytics) and application-specific digital assays for cytotoxicity, mitochondria, lipid droplets, and T cell analysis. The integrated hardware-software platform targets biotech, pharmaceutical, cosmetics, and academic research customers, enabling long-term monitoring of living cells without dyes, labels, or phototoxicity.

Is Nanolive a public or private company?

Nanolive is a private company. It is classified as venture growth investor backed and is currently operating.

When was Nanolive founded?

Nanolive was founded in 2013. It employs 11 to 50 people.

Where is Nanolive based?

Nanolive is headquartered in Ecublens, Switzerland, in the Europe region.

How does Nanolive make money?

Four revenue lines are on record. Hardware Sales - 3D Cell Explorer Platforms are the primary driver. The others are AI-Powered Software Analytics, digital Assays (EVE Assays) and accessories and Consumables.

Does Nanolive have an API?

No public API is recorded for Nanolive.

What industry is Nanolive in?

Nanolive's product category is Scientific Instrumentation. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comDigital Holographic Microscopy Market to Reach USD 3,056.89 Million by 2033 | North America Leads with 38% Share | Key Players: Lyncee Tec, Nanolive, HoloxicaThe global digital holographic microscopy market reached USD 476.60 million in 2024 and is projected to reach USD 3,056.89 million by 2033, growing at a CAGR of 20.4% during the forecast period 2025–2033. The market growth is driven by increasing demand for label-free, non-invasive imaging technologies in biomedical research, drug discovery, and nanotechnology, with North America leading at 38% market share followed by Europe at 30% and Asia Pacific at 24%. Key players including Lyncee Tec, Nanolive, Holoxica, Phase Holographic Imaging AB, Ovizio Imaging Systems, Holmarc Opto-Mechatronics Ltd, and Daeil Systems are intensifying innovation in next-generation DHM platforms and AI-integrated imaging solutions.startupticker.chSportradar and Nanolive founders win ‘EY Entrepreneur of Year’ AwardSportradar's Carsten Koerl and Nanolive's Yann Cotte won the 25th EY Entrepreneur of the Year awards. Koerl's company employs 3,000 people and went public in 2021, while Nanolive's 3D cell-observation technology is 95% exported. The jury selected winners from four categories.BioAlpsNanolive SA closes a series C round at $22.2 millionSwiss biotech company Nanolive SA has closed a $22.2 million Series C equity financing round led by Innoviva, a NASDAQ-listed US life science company, and Taiwania Capital, a Taiwan-based venture capital firm. The funding will support the company's development of label-free live cell imaging and digital analytical solutions for drug discovery and cell therapy. Nanolive also announced the appointment of Dr. Deborah Birx, former U.S. Coronavirus Response Coordinator, and Victoria Wang of Taiwania Capital to its board of directors.startupticker.chAdditional $2.2 million and seasoned board members for NanoliveNanolive SA has closed its Series C funding round at $22.2 million, securing an additional $2.2 million from investors including Innoviva and Taiwania Capital. Concurrently, the company appointed Victoria Wang and Deborah Birx to its board of directors to support its strategic growth. The firm also launched the LIVE Cell Death Assay, a new automated solution for label-free cell health profiling.TaiwaniacapitalNanolive SA Announces Initial Closing of Series C-1 RoundNanolive SA has completed the initial closing of a $20 million Series C-1 equity financing round, led by a NASDAQ-listed US life science investor and Taiwania Capital. The company plans to secure a second close within ninety days to support its digital assay solutions for drug discovery and cell therapy.startupticker.chNanolive banks $20 million in Series C1 roundNanolive announced the first closing of its Series C1 financing round, raising $20 million led by a US-based NASDAQ-listed life science investor and Taiwania Capital. The funding will support the growth of Nanolive's label-free microscope devices and AI-assisted digital analytical solutions for drug discovery and cell therapy research. Existing investors including Swisscom Ventures and transaction advisor Locust Walk also participated in the round.PR NewswireWorldwide Medical Holography Industry to 2026 - The Emergence of Holography Technology to Represent Complex 3D Structures is Driving GrowthResearchAndMarkets.com announced the addition of a "Medical Holography Market 2020-2026" report, projecting considerable growth in the global medical holography market during the forecast period. Key growth drivers include the expanding clinical applications of holography and the emergence of technology to represent complex 3D structures, while high computational costs for processing holograms may restrain market growth. North America is expected to hold a significant market share due to high healthcare expenditure and adoption rates, with Asia-Pacific anticipated to show considerable growth driven by rising chronic disease prevalence.startupticker.chGlobal accolades for Swiss innovationsSwiss startups DEPsys, Nanolive, and several insurtech and tech firms won global awards in 2019. DEPsys received Frost & Sullivan's European New Product Innovation Award for its grid optimization platform, while Nanolive's CX-A microscope was named a Top 10 innovation by The Scientist. Three Swiss startups also placed in the Top 10 of IPIEC Global in China.startupticker.chSwisscom invests in NanoliveSwisscom invested CHF 500,000 in Nanolive, a Swiss start-up that developed a 3D cell exploration technology. The investment comes from Swisscom Ventures' Early Stage Fund after Nanolive won the StartUp Challenge and completed a Silicon Valley mentor program. The company aims to use the technology for real-time drug testing in medical research.